Monitoring the Occurrence of Antibiotic-Resistant Bacteria in the Triplett Creek Watershed by Polymerase Chain Reaction by Gearner, Geoffrey W.
MSU ARCHIVES 
91A5 
Monitoring the Occnrrence of Antibiotic-Resistant Bacteria in the Triplett Creek Watershed by 
Polymerase Chain Reaction· 
Final Report for the Morehead State University Research & Creative Prodnctions Committee and 
the Institute for Regional Analysis & Public Policy 
Geoffrey W. Geamer 
Professor 
Dept. of Biological & Environmental Sciences 
Morehead State University 
3 0 September 2003 
The original research objectives of the project were to: 
I. Collect water samples form a variety of sites in the Triplett Creek watershed and analyze each for 
the presence of total coliform, fecal coliform and fecal streptococci bacteria. 
2. To assess selected bacterial isolates for resistivity to a panel of antibiotics. 
3. To identify these isolates to genus and species. 
4. To assess their ability to transfer antibiotic resistance (R) factors to recipient bacteria. 
5. To develop and optimize a PCR assay to directly test isolates for R factors. 
6. To develop a database of characterized isolates that could be used to: 
a. track the occurrence of antibiotic resistant bacteria in the watershed over time; 
b. develop GIS models of the watershed; and 
c. address public policy issues concerning the watershed. 
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Water samples were collected from 27 sites m the Tnplett Creek wa~ershed (see Table I and') iLn/J 
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Figure I) at various times from August 2001 to March 2003 (see Table 2). 'fypically,--tWo lOO~rrili-
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samples were collected in Whirl-Pak sample bags (Nasc_o) from each site and stored on ice for transport·-- ... 
Methods Employed 
back to the lab. Samples were processed within eight hours of collection. 
Bacteriological Analysis 
An aliquot of water from each site was filtered by aspiration through a 0.45-µm pore size 
membrane filter (Millipore Corp), Filters were transferred to selective/differential media and bacterial 
counts were determined after appropriate incubation (see Table 3 for media and incubation conditions) (! 
- 3). 
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Figure 1. Key to water collection sites on the Triplett Creek watershed. The red line indicates the main 
stem of Triplett Creek; the yellow lines indicate major tributaries of Triplett Creek; the green dots indicate 
collection sites. 
. . .. 
Table 1. Key to Sites on the Triplett Creek Watershed 
Site# Description GPS Coordinates GPS Elev. 
HB-01 Log Cabin Bridge 38°15'44.3"N 83°19'59.1"W 923' 
HB-02 Poppy Mountain 38°15'31.8"N 83°19'58.9"W 914' 
TC-01 Haldeman Fire Station 38°14'27.4"N 83°21'06.6"W 865' 
TC-02 MSU Golf Course 38013'31. 7"N 83°22'44.1 "W 822' 
TC-03 Steven's Used Cars 38°12'34.6"N 83°23'48.1 "W 794' 
TC-04 Rodburn Elementary 38°11 '46.5"N 83°24'32.3"W 790' 
CC-01 3317 Christy Creek 38°11 '02.3"N 83°16'49.8"W 1004' 
CC-02 Brinegar 38°11 '31.2"N 83°18'15.3"W 935' 
CC-03 Seas Branch 38°11'13.6"N 83°19'42.8"W 897' 
CC-04 Old House Creek Road Bridge 38°11'01.9"N 83°20'39.9"W 868' 
CC-05 Lee Branch Bridge 38°11 '07 .9"N 83°21'14.1"W 
CC-06 SAE Fraternity House 38°11 '18.9"N 83°22'35.7"W 830' 
CC-07 Tackett Road Bridge 38°11 '26.0"N 83°22'42.4"W 824' 
CC-08 Mabry's (confluence w/ TC) 38°11 '34.4"N 83°24'40.8"W 790' 
TC-05 Tolliver Road Bridge 38°11 '29.8"N 83°24'57.4"W 769' 
EB-03 MSU Parking Lot 38°11'10"N 83°25'45"W 
TC-06 Morehead City Park 38°10'57.5"N 83°25'49.0"W 752' 
TC-07 Old Water Treatment Plant 38°10'01.5"N 83°26'22.9"W 735' 
DC-01 Nichols Branch Bridge 38°09'16.5"N 83°23'41.0"W 819' 
DC-02 Old Vacant Lot (0.64 mile) 38°09'50.9"N 83°24'53.0"W 774' 
DC-03 Near 519 Bridge 38°09'49.6"N 83°25'52.6"W 749' 
TC-08 Pack's Estates 38°09'12.4"N 83°27'37.6"W 718' 
TC-09 HWY 60 Bridge 38°08'4 7 .2"N 83°30'43.5"W 
NF-01 Cross Creek Road 38°16'07"N 83°25'34"W 
NF-03 Bullfork Rd. Bridge 38°09'49.3"N 83°30'44.4"W 
BB-03 Church of God 38°12'42"N 83°28'11''W 
TC-10 Old 801 Bridge (Farmers) 38°08'53.9"N 83°32'51.2"W 718' 
TC = Triplett Creek NOTE: For each creek, the 
HB = Hayes Branchl higher the number, the 
CC = Christy Creek closer to its mouth. 
DC = Dry Creek 
NF = North Fork of Triplett Creek 
BB = Big Brushy Creek 
EB = Evans Branch 
Table 2. Dates samples were collected at each collection site. 
Collection Date 
2001 2002 2003 
Collection Sitea 8-8 8-22 2-13 6-26 9-23 11-22 3-31 
TC-10 + + + + + + 
TC-09 + + + + + + 
TC-08 + + + + + + 
TC-07 + + + + + 
TC-06 + + + + + 
TC-05 + + + + + 
TC-04 + + + + + 
TC-03 + + + + + 
TC-02 + + + + + + 
TC-01 + + + + + 
CC-08 + + 
CC-07 + + + + + + 
CC-06 + 
CC-05 + 
CC-04 + + 
CC-03 + 
CC-02 + 
CC-01 + 
BB-03 + 
NF-01 + 
DC-01 + 
DC-02 + 
DC-03 + + + + 
EB-03 + 
•Tc, Triplet Creek; CC, Christy Creek; DC, Dry Creek; NF, North Fork of Triplett Creek; BB, Big Brush Creek;, 
EB, Evans Branck. 
Table 3. Media and incubation conditions for bacteriological analysis of water samples. 
Incubation Incubation Bacteria 
Medium Temperature Time Detected 
M-ENDO 37'C 24 hours Total coliforrns 
M-FC 42'C 24 hours Fecal coliforrns 
M-ENTEROCOCCUS 37'C 48 hours Fecal streptococci 
Antibiotic Susceptibility Analysis 
Isolated colonies were selected from the M-FC plate cultures and streaked onto tryptic soy agar 
(TSA; Difeo) plates to generate pure cultures. The TSA plates were incubated at 35°C for 24 hours. The 
isolates were then assessed for resistance to a panel of antibiotics using the disk diffusion method. 
Mueller-Hinton broth tubes (Difeo) were inoculated with the isolates and incubated in a shaking incubator 
at 37°C for 4 hours, until they reached log-phase growth. The Mueller-Hinton broth cultures were used to 
inoculate Kirby-Bauer plates (Difeo) to confluency. Up to twelve different antimicrobial susceptibility 
test discs (BBL) were deposited on the Kirby-Bauer plates, then the plates were incubated at 37°C for 18-
20 hours (see Table 4 for antibiotics used). After incubation, the zone of inhibition surround each disk 
was measured ( 4). Zones of inhibition were then compared to published values to determine sensitivity, 
resistance, or intermediate resistance to each antibiotic (5, 6). 
Table 4. Antibiotics used in Kirby-Bauer method. 
Antibiotics 
Erythromycin 
Kanomycin 
Ciprofloxacin 
Tetracycline 
Ampicillin 
Cefazolin 
Carbenicillin 
Doxycycline 
Piperacillin 
Cefuroxime 
Amikacin 
Isolate Identification and Maintenance 
Concentration (µg) 
15 
30 
5 
30 
10 
30 
100 
30 
100 
30 
30 
To identify individual isolates that exhibited resistance to antibiotics, eosin methylene blue agar 
plates were inoculated and incubated overnight at 37°C. Any isolates that exhibited coli-type growth 
(green metallic sheen in appearance) were presumptively identified as Escherichia coli. Confirmation 
was conducted by inoculating an EC-MUG broth tube (Difeo), and indole deep tube (Difeo), an MR-VP 
broth tube (Difeo), and a Simmon's Citrate slant (Difeo) and incubating for 48 hr at 37°C. Any isolates 
that exhibited aerogenes-type growth (pink mucoid appearance with dark centers) or non-lactose 
fermenter growth (no change in the medium) were further evaluated by an-API-20E multiple test strip. 
Briefly, MacConkey's agar plates (Difeo) were inoculated, then incubated overnight at 37oC. A cell 
suspension was produced in saline to a turbidity of a #3 MacFarland's nephelometer standard, then used·to 
inoculate the 20 wells of the API-20E test strip (bioMeneux). The test strips were incubated overnight at 
37oC. The test results were evaluated to generate a profile number that was used to identify the isolate by 
comparison to the Analytical Profile Index (7). 
To produce stocks of the isolates for long term storage, 10-mL tryptic soy broth (TSB; Difeo) 
tubes were inoculated and incubated overnight at 37°C in a shaking incubator. The cultures were 
transferred to sterile 15-mL centrifuge tubes, and centrifuged at 5000 r.p.m. for 10 minutes at 4°C. The 
supernatant was discarded and the cells were resuspended in 800 µL of sterile ice cold TSB. The 
suspension was transferred to sterile 1.2-mL cryotubes. 200 µL of sterile ice cold glycerol was 
transferred to the tubes. The tubes were then stored at -70°C. 
Detection of Integron Sequences by Polymerase Chain Reaction 
Oligonucleotide primers (Integrated DNA Technologies) recognizing the conserved region of the 
class 1 and class 2 integron integrase genes were used to identify the presence of integrons in the fecal 
coliform isolates. Briefly, a 1: 1 dilution was prepared from each stock primer and stored at -20°C. See 
Table 5 for primer sequences and expected product size. Each primer was diluted 1/100 for polymerase 
chain reaction (PCR). Primers were mixed by briefly vortexing, then 2.5 µL of forward and 2.5 µL of 
reverse primer was added to a 0.5-mL PCR tube. Figure 2 shows the class I integron structure and primer 
binding sites. 
Primers corresponding to 168 rDNA were used as a positive control (8). Eschericheria coli 
pDU 202, which contains a class I integron, and Eschericheria coli, Tn7, containing a class 2 integron, 
. . 
were also used as positive controls (courtesy of Dr. Maurer, University of Georgia). Negative controls 
used in every PCR included target DNA with no primers and primers without target DNA. 
Table 5. Oligonucleotide primers used for PCR analysis of class 1 and class II integrons. 
Primer Nuleotide Sequence 
!IE GGAATTCCGAGGAAGGTGGGGATGACGT 
13B CGGGATCCCAGGCCCGGGAACGTATTCAC 
IntA ATCATCGTCGTAGAGACGTCGG 
IntB GTCAAGGTTCTGGACGAGTTGC 
Intl-3F CCTCCCGCACGATGATC 
Intl-3R TCCACGCATCGTCAGGC 
Int2-3F TTATTTGCTGGGATTAGGC 
Int2-3R ACGGCTAGCCTCTGTTATC 
Target Product 
Size 
16SrDNA 233 
Positive control 
Intll 892 
Intll 280 
Intl 2 233 
ill---1-..t x \.~ 
Integrase 
Gene 
5' Conserved Region Variable Region 
qaC.1 E 1 su/ I orf 5 orf6 
3' Conserved Region 
Figure 2. Class 1 integron structure and primer binding sites. Both primer sets, IntA/IntB and Intl-3F/R, 
bind to the conserved region of the integrase gene int!l. The IntA and IntB binding sites are shown by 
bold black arrows; and the Intl-3F and Intl-3R binding sites are indicated by gray arrows (10). 
Microbial DNA used in PCR was liberated from bacterial cells using the Lys-N- Go reagent 
(Pierce). TSA plates were inoculated with frozen cell stock and incubated overnight at 37°C. A colony 
from each plate was picked using a sterile pipette tip and resuspended in 5-10 µL ofLys-N-Go reagent. 
Table 5 indicates the theimalcycler program used. 2.5 µL of template DNA for intll and 1.25 µL 
template DNA for intl2, was added to the PCR tube followed by 5.0 µL of sterile H20. HotStarTaq 
Master Mix (Qiagen) was briefly vortexed to mix and 12.5 µL of Master Mix was added to the tube. 
HotStarTaq Master Mix provides a final MgC12 concentration of 1.5 mM and 200 µM of each dNTP. 
Table 5. Lys-N-Go conditions. 
Cycle Temperature (°C) Time 
1 65 30 seconds 
2 8 30 seconds 
3 65 90 seconds 
4 97 180 seconds 
5 8 60 seconds 
6 65 180 seconds 
7 97 60 seconds 
8 65 60 seconds 
9 80 Hold 
To optimize PCR conditions, magnesium concentrations were varied from 1.5 to 3.0 mM, using 
control cell DNA Tn7 and PDU 202, as well as DNA from a fecal coliform isolate. To alter the 
concentration a stock solution of 25 mM MgC!z was prepared. Table 6 indicates the volume of stock 
MgClz added to obtain the final concentration indicated. Table 7 indicates the thermocycler settings used 
inPCR. 
Table 6. Magnesium chloride concentrations used to optimize PCR. 
Final Mg 2++ concentration 
Volume of25 rnMMgC]z (µL) 
Table 7. PCR conditions. 
Initial Activation 
I. Denaturation 
2. Annealing 
2. Annealing 
3. Extension 
30 cycles of steps 1-3 
Final Extension 
15 min 
I min 
1 min 
I min 
I min 
IO min 
1.5 
0 
2.0 2.5 3.0 
2 4 6 
95°C 
94°C 
52°C (For class I integron primers) 
50°C (For class 2 integron primers) 
72°C 
72°C 
• 
The amount of template DNA was also varied to optimize PCR for the class 2 integrons by using 
different volumes of Lys-N-Go product. A volume of 1.25 µL resulted in the absence of a smeared PCR 
product in most cases. All samples were stored at -20°C until analyzed by gel electrophoresis. 
Gel Electrophoresis 
All PCR products were analyzed by agarose gel electrophoresis. Gels were made by suspending 
1.25 g ofagarose (Fisher) in 100 mL IX TBE (Tris-Borate-EDTA buffer). 5 µL ofloading dye was 
added to each of the PCR tubes. 10 µL ofRNAase was added per 500 µL ofloading dye. In samples 
containing mineral oil, the dye was added directly to the bottom of the tube. 10 µL of sample was loaded 
into the each well. 5 µL of 100 bp DNA ladder (New England BioLabs) was also loaded into one well in 
each gel. Samples were electrophoresed at 120 V for 30-40 minutes. Gels were then stained with 
lµg/mL of ethidium bromide (Sigma) for 15 minutes. After staining, gels were rinsed with H20, 
visualized and photodocumented. 
Results and Discussion 
Bacteriological Analysis 
Tables 8 - 14 summarize the bacterial counts as well as the FC:FS ratios obtained at each sample 
site for each sample period. The FC:FS ratio can be used to differentiate human fecal contamination from 
other warm-blooded animal fecal contamination. A ratio of less than 0. 7 indicates non-human fecal 
contamination, whereas a ratio greater than 4.0 indicates human fecal contamination. A ratio between 0. 7 
and 4.0 can be indicative of a mix of human and animal fecal material. However, because there is some 
question as to the survival rate of fecal streptococci in the environment the reliability of the FC:FS ratio is 
not universally accepted (3). 
As shown in Table 8, the FC:FS ratios for sites TC-9 and CC-7 indicate a mix of human and 
animal fecal contamination. The other sites appear to have only non-human contamination. Nine of the 
twelve sites sampled on 22 August 2001 sample period contained fecal coliforms of both human and 
. . 
animal origin (Table 9). One site, TC-6, also appeared to be contaminated with bacteria of human origin 
(Table 9). 
Table 8. Bacterial counts for the 8 August 2001 collection period. 
Site# TC FC FS FC:FS 
TC-01 1400 360 820 0.44 
TC-02 1120 340 500 0.68 
TC-03 520 60 200 0.30 
TC-04 1240 350 790 0.44 
TC-05 740 140 380 0.37 
TC-06 750 340 1300 0.26 
TC-07 980 260 390 0.67 
TC-08 860 130 780 0.17 
TC-09 590 170 190 0.89 
TC-10 550 56 260 0.22 
CC-07 720 120 140 0.86 
DC-03 2100 216 1190 0.18 
Table 9. Bacterial counts for the 22 August 2001 collection period. 
Site# TC FC FS FC:FS 
TC-01 1300 3100 2670 1.16 
TC-02 380 20 310 0.06 
TC-03 290 170 420 0.40 
TC-04 690 480 320 1.50 
TC-05 560 210 390 0.54 
TC-06 610 190 90 2.11 
TC-07 480 310 230 1.35 
TC-08 300 220 270 0.81 
TC-09 630 340 220 1.55 
TC-10 410 200 230 0.87 
CC-07 370 150 70 2.14 
DC-03 1050 1000 530 1.89 
• 
Six of the eight sights from the 13 February 2002 collection period had FC:FS ratios that 
indicated a mix of human and animal origin (Table 10). In addition, one site, TC-10 had a high ratio 
indicating contamination of human origin. Five of the seven sites sampled 26 June 2002 indicated a mix 
(Table 11). One of the site from the 23 September 2002 sample period contained fecal coliforms of both 
human and animal origin (Table 12). Twelve sites from the 23 November 2002 collection indicated a mix 
of human and animal fecal material, while one site, TC-03 appeared to be predominately of human origin 
(Table 13). Finally, six sites from the 31 March 2003 sample period contained fecal coliforms of both 
human and animal origin, and at least 3 sites appeared to be of human origin (Table 14). 
Two collection times are worth noting here, 23 September 2002 (Table 12) followed a six-week 
dry period in Rowan County, whereas 22 November 2002 (Table 13) followed a relatively wet period in 
the county. Comparison of these two samplings shows that bacteria counts were generally low and that 
FC:FS ratios indicate contamination of animal origin following the dry period; whereas bacterial counts 
were much higher following the wet period during which water is flushed into the drainage, carrying 
bacteria with it. Only one site (TC-03) had an FC:FS ratio indicating human fecal contamination from 
the 22 November 2002 collection. If there were significant and continuous straight pipe sewage 
deposition into the watershed, we would expect FC:FS ratios to be greater than 4.0 (lower water flow, 
high bacterial density) during dry periods. These data do not support that conclusion. We would expect 
bacterial counts to be higher following a rain event as water from pastures, farms, etc., flushes microbes 
into the drainage, and that FC:FS ratios would indicate fecal contamination of animal or a mix of human 
and animal origin. The data do support this conclusion. 
. . . 
Table 10. Bacterial counts for 13 Febru~ 2002 collection Eeriod. 
Site# TC FC FS FC:FS 
TC-01 310 20 8 2.50 
TC-02 0 20 12 1.67 
TC-04 90 20 8 2.5.0 
TC-08 210 70 24 2.92 
TC-09 1100 0 24 0.00 
TC-10 840 370 36 10.28 
CC-07 80 40 0 0.00 
DC-03 100 50 40 1.04 
Table 11. ·Bacterial counts for the 26 June 2002 collection period. 
Site# TC FC FS FC:FS 
CC-01 54 248 46 0.54 
CC-02 56 480 34 1.41 
CC-03 52 500 48 1.04 
CC-04 8 400 40 1.00 
CC-05 78 620 . 48 1.29 
CC-06 12 480 24 2.00 
CC-08 50 85 28 0.30 
Table 12. Bacterial counts for the 23 September 2002 collection period. 
Site# TC FC FS FC:FS 
TC-02 340 72 230 0.31 
TC-03 72 284 0.25 
TC-05 224 8 12 0.6 
TC-06 324 140 14 1.0 
TC-07 368 52 114 0.45 
TC-08 164 106 84 0.63 
TC-09 620 288 330 0.8 
TC-10 164 40 124 0.32 
. . . 
Table 13. Bacterial counts for the 22 November 2002 collection period. 
Site# TC FC FS FC:FS 
TC-01 1520 400 155 2.58 
TC-02 2680 370 200 1.85 
TC-03 970 1320 240 5.50 
TC-04 500 250 405 0.62 
TC-05 1000 220 515 0.43 
TC-06 1200 420 715 0.59 
TC-07 520 370 420 0.88 
TC-08 600 160 340 0.47 
TC-09 600 160 340 0.47 
TC-10 380 3040 1085 2.80 
CC-04 1880 970 445 0.99 
CC-07 1240 440 445 2.18 
CC-08 830 460 455 1.01 
DC-02 300 140 70 2.00 
DC-03 220 190 115 1.65 
EC-03 69 160 370 0.43 
NF-01 690 490 265 1.85 
BB-03 1760 1760 455 3.87 
Table 14. Bacterial counts for the 31 March 2003 collection period. 
Site# TC FC FS FC:FS 
TC-02 100 0 8 0 
TC-03 170 10 12 0.83 
TC-05 290 140 36 3.90 
TC-04 130 10 32 0.31 
TC-06 300 140 52 2.70 
TC-07 470 490 40 12.25 
TC-08 1200 170 48 3.54 
TC-09 1090 780 104 7.50 
TC-10 2680 1370 156 8.78 
Antibiotic Susceptibility Analysis 
Ninety-two of the one hundred and thirty two isolates tested (68.7%) exhibited resistance to one 
or more antibiotics. Thirty-two (23.9%) of the isolates were resistant to three or more antibiotics. 
Tables 15 -19 shows the resistance profiles for each sample period and Figures 3 - 7 indicate the percent 
of isolates resistant or intermediate resistant to the antibiotics tested for each sample period. 
Table 20 summarizes the percent of total isolates tested that were resistant or intermediate for 
each antibiotic. The high level of erythromycin resistance observed can be contributed to the intrinsic 
resistance of gram-negative bacteria to macrolides. A moderate level of resistance was also observed to 
the P-lactam antibiotics, cephalosporins and penicillins. Between the two cephalosporins tested, a higher 
percentage ofresistance (17.3%) and intermediate resistance (10.5%) was observed to the first generation 
cephalosporin than to second generation (2.5% resistant and 7.6% intermediate). Among the penicillins, 
isolates exhibited the highest level ofresistance (30.1%) and intermediate resistance (18.8%) to 
ampicillin. Among the aminoglycosides, bacterial isolates exhibited a high percent ofresistance (24.6%) 
and intermediate resistance (46.4%) to streptomycin. 
An interesting observation was made when antibiotic resistance patterns are compared to 
potential origin of fecal contamination (Table 20). There appears to be a correlation of a resistance 
profile (streptomycin, amikacin, trymethoprim, and cephosporins) to presumptive human source bacterial 
isolates. This observation warrants further exploration as it may lend support to the validity ofFC:FS 
ratios as indicators of the source of fecal contamination. 
. . 
Table 15. Antibiotic Resistance Profile for fecal coliform isolates from 13 February 2002. 
Antibiotic a 
Isolate s TMP D TE CZ CXM CIP PIP AM CB 
TC-4-1 
TC-4-2 
TC-4-3 
CC-7-1 
CC-7-2 
CC-7-3 
r~~=~ 
R R',.I S 
I '~> .. 
R ... ~:'.r 
.R fR 
S S R S 
Bs :R 
S S R 
' 
TC-8-1 
TC-8-2 
TC-8-3 
TC-2-1 
TC-2-2 
TC-2-3 s 
DC-3-1 s 
TC-1-1 D s 
TC-10-1 s s s 
aStreptomycin (S) 10 µg, Trimethoprim (1MP) 5 µg, Erythromycin (E) 15µg, Kanomycin (K) 30µg, Ciprofloxacin 
(CIP) 5µg, Tetracycline (TE) 30µg, Ampicillin (AM) !Oµg, Cefazolin (CZ) 30µg, Carbencillin (CB) IOOµg, 
Doxycycline (D) 30µg, Piperacillin (PIP) !OOµg, Cefuroxime (CXM) 30µg, Amikacin (AN) 30µg. 
• 
Table 16. Antibiotic Resistance Profile for fecal coliform isolates from 26 June 2002. 
Antibiotic a 
TMP E K AN D TE CZ CXM CIP PIP AM CB 
r '· lls I'' eJ' iRc<: S s s s s s s s ;_-,-.. ~:] • CC-01-2 tR~:s s s s s s s s s y:;, •s CC-01-3 R•·>" S s s s s s s s 
~-- K~· s s s s s s s s s s CC-02-3 •R: .. s s s s s s s s •s 
- IR? s s s s s s s s s s __ ,_,,,.,, ____ s s s s s s s s s s . CC-03-2 r-~-: s s s f -~. s s s s s s s 
CC-03-3 R·'' s s s s s s s s •s 
CC-04-1 
l'1:P: 
!WI :8~;·. s s s s s s s CC-04-2 r~~l: R S lR R°'Lls S S CC-04-3 :131~: s s s s s -s s . 
CC-04-4 I~'' s s · !R . R.~•~"'i;ls s s s s s ~-\,~'.4_;: I' - ' - t _j 
~ 
CC-05-1 !~gs s s s s s s 
CC-05-2 !fyL' , , , , , s SIR :· 
CC-05-3 R< 1·s. s s s ![:Js s -R i ;1 
CC-05-4 :R;1,. S S S S S S s R s 
CC-06-1 t~~':Js s s s s s s s •s 
CC-06-2 Ms s s s s s s s s 
" " I CC-06-3 iR''· S s s s s s s s I , 
CC-07-1 :R.'•·'S s s s s s s s 
1:~: .. 
CC-08-1 tR"s: __ s s s s s s s s 
CC-08-2 
I "· ... s s s s s s s s 'R~.' 
CC-08-3 s s s s s s s s 
•streptomycin (S) 10 µg, Trimethoprim (1MP) 5 µg, Erythromycin (E) 15µg, Kanomycin (K) 30µg, Ciprofloxacin 
(CIP) 5µg, Tetracycline {TE) 30µg, Ampicillin {AM) IOµg, Cefazolin (CZ) 30µg, Carbencillin (CB) IOOµg, 
Doxycycline (D) 30µg, Piperacillin (PIP) I OOµg, Cefuroxime (CXM) 30µg, Amikacin (AN) 30µg. 
.. 
Table 17. Antibiotic Resistance Profile for fecal coliform isolates from 23 September 2002. 
Antibiotic a 
Isolate S TMP E K AN D TE CZ CXM CIP PIP AM CB 
TC-8-1 
TC-8-2 
TC-3-1 
TC-.3-2 
TC-3-3 
TC-3-4 
TC-9-1 
TC-9-2 
TC-9-3 
TC-5-1 
TC-5-2 
TC-5-3 
TC-5-4 
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7 -1-
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7-3-
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"streptomycin (S) IO µg, Trimethoprim (1MP) 5 µg, Erythromycin (E) 15µg, Kanomycin (K) 30µg, Ciprofloxacin 
(CIP) 5µg, Tetracycline (TE) 30µg, Ampicillin (AM) !Oµg, Cefazolin (CZ) 30µg, Carbencillin (CB) !OOµg, 
Doxycycline (D) 30µg, Piperacillin (PIP) IOOµg, Cefuroxime (CXM) 30µg, Amikacin (AN) 30µg. 
. ' 
Table 18. Antibiotic Resistance Profile for fecal coliform isolates from 22 November 2002. 
Antibiotic 
a 
Isolate s TMP E K AN D TE CZ CXM CIP PIP AM CB 
CC-08-1 s s s s s s s s s s fR !'as 
CC-08-2 -s s s s s s s s s s s 
CC-08-3 s s s s s s s s s s !!lilllS 
CC-07-1 s s s s s s s s s s s s 
s s s s s s s s s s s 
CC-07-3 s s s s s s s s s [R .: ;t,•jS 
CC-04-1 s s s s s s s s s s s 
CC-04-2 s s s s s s s s !R~ ·~Z'Js 
DC-02-1 s s s s s ~s s s s s DC-02-2 •s s s s s s s s 
---·-.~."" DC-02-3 s s s s s s s :R . R •.. rt1S 
DC-03-1 I s s s s s s s s s s s 
DC-03-2 s s s s s s s s s s s 
DC-03-3 s s s s s s s s s s s 
DC-01-1 s •s s s s s s s s s 
EC-03-1 s s s s s s s s s !R ,,.i;:;is 
BB-03-1 s I s s s s s s s s s 
BB-03-2 s s s s s s s s iR R=:;ms 
BB-03-3 s -s s s s s s s s s 
NF-01-1 s s s s K:]s s s s s 
NF-01-2 s s s s s s s s s s 
NF-01-3 s -s s s s s s s s s 
TC10-1 s s s s s s s s s s s 
TC-10-2 s s s [B.'.r '.R=:;:Js s s s s s 
TC-10-3 s s s s s s s s s s s 
TC-09-1 s s s s s s s s s s s s 
TC-08-1 -s s s s s s s s s s s 
TC-08-2 s s s s s s s s s s rR 
TC-07-1 E]s s s s s s s s s IR 
TC-07-2 s s s s s s s s s s 
TC-06-2 
TC-06-1 ~ls s s 
--~n s s s s s •R•f,, RS 
TC-05-1 
~ 
s s s s s s s s s s 
TC-05-2 s s s [ms s s s s s 
TC-05-3 s s s s s s s s s s s 
TC-04-1 s s s s s s s s s s s 
TC-03-1 S 'R-71 s s s s ~as -~·:<:rl~ TC-03-2 ':.........J ·i s s s s J ,. R R ... ,, 1R R. !'.f;''S 
';:;--J . ' ··~ TC-03-3 S <R .><i s s s s B.._I· . ''S s s s 
TC-02-1 ms-- s s ms s s s s s s 
:rc-02-2 s s s s s s s s s 
~i TC-02-3 lR!S s s s s E:JS s I --~-c;:i TC-01-1 JR R_ -'L:., s s s s s s s -~}'·~ TC-01-2 s s s s s s s s s TC-01-3 •s s s s s s s s R_. t' S 
Streptomycin (S) 10 µg, Trimethoprim (TMP) 5 µg, Erythromycin (E) 15µg, Kanomycin (K) 30µg, Ciprofloxacin 
(CIP) 5µg, Tetracycline (TE) 30µg, Ampicillin (AM) IOµg, Cefazolin (CZ) 30µg, Carbencillin (CB) IOOµg, 
Doxycycline (D) 30µg, Piperacillin (PIP) IOOµg, Cefuroxime (CXM) 30µg, Amikacin (AN) 30µg. 
.. 
Table 19. Antibiotic Resistance Profile for fecal coliform isolates from 31March2003. 
Isolate 
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ffiC!jj# 
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Streptomycin (S) 10 µg, Trimethoprim (TMP) 5 µg, Erythromycin (E) 15µg, Kanomycin (K) 30µg, Ciprofloxacin 
(CIP) 5µg, Tetracycline (TE) 30µg, Ampicillin (AM) IOµg, Cefazolin (CZ) 30µg, Carbencillin (CB) lOOµg, 
Doxycycline (D) 30µg, Piperacillin (PIP) !OOµg, Cefuroxime (CXM) 30µg, Amikacin (AN) 30µg. 
' . 
Pecent of Fecal Coliform Isolates Exhibiting Resistance or Intermediate 
Resistance for 02-13-2002 
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Figure 3. Percent of fecal coliform isolates exhibiting resistance or intermediate resistance to the 
antibiotics tested for the 13 February 2002 collection period. 
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Figure 4. Percent of fecal coliform isolates exhibiting resistance or intermediate resistance to the 
antibiotics tested for the 26 June 2002 collection period. 
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Percent·of Fecal Coliform Isolates Exhibiting Resistance or 
Intermediate Resistance for 09-23-2002 
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Figure 5. Percent of fecal coliform isolates exhibiting resistance or intermediate resistance to the 
antibiotics tested for the 23 September 2002 collection period. 
Percent of Fecal Coliform Isolates Exhibiting Resistance or 
Intermediate Resistance for 11-22-02 
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Figure 6. Percent of fecal coliform isolates exhibiting resistance or intermediate resistance to the 
antibiotics tested for the 22 November 2003 collection period. 
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Percent of Fecal Coliform Isolates Exhibiting Resistance or 
Intermediate Resistance for 3-31-2003 
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Figure 7. Percent of fecal coliform isolates exhibiting resistance or intermediate resistance to the 
antibiotics tested for the 31 March 2003 collection period. 
; . 
Table 20. The percent resistance and percent intermediate resistance to the antibiotic class (antibiotics) tested for the total number 
of isolates tested as well as for those isolates of presumptive human, animal, and a mix of human and animal origin. 
Antibiotic Class Total# Isolates (133) Hwnan Isolates (15) Animal Isolates (3 6) Isolates Hwnan/ Animal Mix (82) 
#Isolates #Isolates #Isolates #Isolates 
Antibiotic Tested %R %I Tested %R %I Tested %R %I Tested %RI% 
Aminoglycosides 
Streptomycin 69 24.6 46.38 11 63.64 36.36 -13 30.77 46.15 44 18.18 47.73 
Kanomycin 133 3.76 10.53 15 13.33 26.67 36 2.78 0 82 2.44 12.20 
Amikacin 118 6.78 1.69 15 40.00 20.00 32 9.38 3.13 71 9.23 0 
Sulfonamide 
Trimethoprim 69 7.25 1.45 11 45.45 0 13 0 5.38 44 2.27 0 
Floroquione 
Ciprofloxin 33 3.78 1.5 15 13.33 0 36 5.56 0 82 2.44 0 
(Beta-Lactams) 
Cephalosporin 
Cefazolin (1'1 generation) 133 17.29 10.53 15 46.67 13.33 36 11.11 13.89 82 13.41 13.41 
Cefuroxime (2°' generation) 118 2.54 7.63 14 21.43 26.67 32 0 9.38 71 0 2.82 
Penicillins 
Ampicillin 133 30.l 18.8 15 40.00 6.67 36 22.22 19.44 82 30.49 9.76 
Piperacillin 133 10.53 12.03 15 20.00 33.33 36 13.89 2.78 82 10.98 13.41 
Carbenicillin 133 13.53 8.28 15 13.33 6.67 36 13.89 30.56 82 13.41 4.88 
Tetracycline' 
Tetracycline 133 9.77 5.26 15 6.67 13.33 36 11.11 8.33 82 8.54 4.88 
Doxycycline 133 12.78 0.53 15 6.67 6.67 36 11.11 8.56 82 12.20 14.63 
PCR Detection of Integron Sequences 
Integrons are gene capture systems present in the genomes of certain bacteria, and are often 
associated with antibiotic resistance in bacteria. We wanted to see ifthere was a correlation between 
resistance and the presence of integron sequences. 132 fecal coliform isolates were assessed by PCR. 
Figure 8 shows a typical PCR result as assessed by agarose gel electrophoresis. The class I integron 
integrase gene, intll, was detected in seven of the isolates of the 132 isolates (5.3%) assessed by PCR 
(see Table 21). None of the 132 isolates assessed for the class II integron integrase gene, int/2, resulted in 
a PCR product. All of the integron-positive isolates that were tested for identification keyed out as 
Escherichia coli. There was no correlation of antibiotic resistance and presence or absence of integrons. 
•• 
Figure 8. Ethidium bromide-stained 1.25% agarose gel of PCR products. Lane 1, 100 bp DNA ladder; 
lane 2, intNintB primers only; fane 3, pDU202 template only; lane 4 pDU202 (Int-I-I +control) 
+ intNintB primers; lane 5, pDU202 + 168 rRNA primers; lane 6, isolate TC-05-03 + intNintB primers; 
lane 7, TC-05-03 + 168 rRNA primers; lane 8, isolate CC-08-01 + intA/intB primers; lane 9, CC-08-01 + 
168 rRNA primers; lane 10, isolate CC-01-11 + intA/intB primers; lane 11, isolate CC-02-06 + intNintB 
primers. 
' ' 
Table 21. Results of PCR detection ofintegron sequences in selected fecal coliform isolates. 
Collection Date 
Isolate# (Intl!+) Organism 
11-22-30 
CC-07-2 
03-31-03 
TC-10-2 
TC-3-1 
*06-26-02 
CC-01-1 
CC-02-1 
CC-02-3 
CC-03-1 
Escherichia coli 
Escherichia coli 
Eschericha coli 
Antibiotic 
Resistance Profile 
s (I) 
S, TMP, CZ, PIP (R) 
K, CXM(I) 
S, CXM(I) 
CZ,AM(R) 
CZ (I) 
Isolate Source 
(FC:FS) 
Mix (0.99) 
Human (8.78) 
Mix(0.83) 
Animal (0.54) 
Mix (1.41) 
Mix (1.41) 
Mix (1.04) 
a Streptomycin (S), Trimethoprim (TMP), Cefazolin (CZ), Piperacillin (PIP), Kanomycin (K), Cefuroxime (CXM), 
Ampicillin (AM). Intermediate Resistance (I), Resistant (R). 
b An FC:FS ratio of0.7-4.0 indicates a mix ofhumau and animal fecal contamination. A ratio less than 0.7 is 
predominately animal and a ratio above 4.0 indicates mainly fecal contamination predominately of human origin (3). 
Assessment of Projects Objectives 
>:. Collect water samples form a variety of sites in the Triplett Creek watershed and analyze each for 
the presence of total coliform, fecal coliform and fecal streptococci bacteria. 
This objective was achieved. 
>:. To assess selected bacterial isolates for resistivity to a panel of antibiotics. 
This objective was achieved. 
>:. To identify these isolates to genus and species. 
This objective was achieved. 
>:. To assess their ability to transfer antibiotic resistance (R) factors to recipient bacteria. 
This objective was not met because the results show that there was no correlation between antibiotic 
resistance and a known genetic element often associated with antibiotic resistance. 
>:. To develop and optimize a PCR assay to directly test isolates for R factors. 
This objective was partially achieved in that we applied and optimized a PCR method to test for 
antibiotic resistance factors. 
~ To develop a database of characterized isolates that could be used to: 
o track the occurrence of antibiotic resistant bacteria in the watershed over time; 
This objective was achieved. 
o develop GIS models of the watershed; and 
We are just now beginning to develop a GIS of Rowan County that will allow us to meet 
this objective. 
o address public policy issues concerning the watershed. 
This objective is ongoing and has lead us to form a working relationship with 
Congressman Hal Roger's P.R.I.D.E. program that does in fact address the public issue of 
clean water. The work of this project lead us in that direction and we were successful in 
securing extramural funding to continue monitoring the occurrence of fecal coliform 
bacteria in the Triplett Creek watershed, as well as the watershed of other P .R.I.D.E. 
counties; and to conduct Escherichia coli source tracking. 
Impact of the Project 
Presentations 
Two presentations were given at professional meetings during the course of the project: 
~ 2001. "The occurrence of antibiotic-resistant coliform bacteria in the Triplett Creek watershed, 
Rowan County, Kentucky". Mary N. Williams, Tina L. Howard, and Geoffrey W. Geamer. 
Tennessee Academy of Science/Kentucky Academy of Science Joint Meeting, 9 November 200 I, 
Murfreesburo, TN' 
~ 2003. Howard-Ousley, T., and G. W. Geamer. Assessment of Antibiotic Resistance in Fecal 
Coliform Bacteria in the Triplett Creek Watershed, Rowan County, Kentucky. American Society 
of Microbiology 103'• General Meeting, Washington D.C., May 2003. 
Publications 
A manuscript is currently in preparation, with the goal of submission by December 2003. 
. . 
Grant Funding 
The results of this project allowed us the opportunity to seek extramural funding: 
>- 2003-05. The Upper Licking River Watershed: Teaching and Monitoring Through PRIDE. East 
Kentucky P.R.I.D.E./National Oceanic and Atmospheric Administration (Co-P.I. with Dr. Brian 
Reeder). $298,938. (Approximately 12% [$35,000] of these funds are devoted to my part of the 
project is, Escherichia coli source tracking in watersheds) 
Student Participation 
Two graduate students, four undergraduate special problems students, and 115 students in five 
sections of BIOL 317 (Spring 2001 - Spring 2003) participated in the project. One of the graduate 
students will be graduating in December 2003 with a Master of Science degree. Three of four of the 
special problems students are now in professional school (one in medical school, one in a physician 
assistant program, and one in dental school), while the fourth is likely to gain acceptance into medical 
school for the Fall 2004 semester. One graduate and one undergraduate student were co-authors of the 
professional presentation. This project allowed the students enrolled in BIOL 317 to engage in the process 
of science in a meaningful and significant way. Most students had a very positive experience with the 
project. Students, working in groups, were tasked with producing a poster reporting the results of their 
participation in the project (see Figure 9 for an example). 
' . 
Figure 9. Example of a student-generated poster reporting the results of testing water samples for the 
presence of antibiotic-resistant bacteria. 
Expenditures 
See Table 22 for an accounting of how the grant funds were spent. 
' . 
Table 22. Expenditure of grant funds. 
Vendor Items Price Order Date 
Qiagen Ho!Star!Taq Master Mix 172.00 2/21/01 
MSU Water Testing Lab Bacteriological culture medium 240.00 3/3/01 
BioMerieux API 20E Kit - 25 strips 202.59 4/9/01 
BioMerieux Analytical Profile Index 91.00 4/9/01 
Sigma-Aldrich Chemicals 74.61 4/9/01 
Slides.com Presentation Slides for KAS meeting 67.50 11/1/01 
Fisher Scientific Antibiotic disks (15 different types) 695.29 1217/01 
Fisher Scientific Colony counter marker 151.96 12/7/01 
Fisher Scientific Disc-Dispenser System 322.50 12/7/01 
ASM Press Diagnostic Molecular Biology 85.55 3/1/02 
Sigma-Aldrich Antibiotics (3 different types) 215.96 3/14/02 
Integrated DNA Technologies Oligonucleotides (8 different primer sequences) 84.45 3/19/02 
Kinko's Presentation Poster for ASM meeting 117.13 5/10/02 
Pro mega pGEM®-T Easy Vector System I 150.00 6/24/02 
Integrated DNA Technologies Oligonucleotides (4 different primer sequences) 60.00 6/24/02 
Fisher Scientific Agarose (2) 285.61 9/12/02 
Fisher Scientific Antibiotic disks (4 different types) 197.56 9/12/02 
Fisher Scientific PCR reaction tubes (2 packs) 79.20 9/12/02 
Fisher Scientific Bacteriological culture medium 40.34 9/12/02 
Fisher Scientific Culture plates 53.61 9/12/02 
Fisher Scientific Chemicals 26.31 9/12/02 
Fisher Scientific Pipe! tips (2 packs) 51.84 9/12/02 
Fisher Scientific Parafilm 32.50 9/12/02 
Qiagen Ho!Star!Taq Master Mix 190.07 9/12/02 
New England BioLabs 100 bp DNA Ladder 71.00 9/12/02 
BioMerieux AP I 20 E Kit - 25 strips 202.59 9/12/02 
Integrated DNA Technologies Oligonucleotides (5 different primer sequences) 91.80 11/13/02 
Fisher Scientific Cryopreservation tubes, racks & boxes 252.48 11/18/02 
Fisher Scientific Restriction endonuclease 86.72 11/18/02 
Qiagen Ho!Star!Taq Master Mix 190.07 12/9/02 
TOTAL 4582.24 
I • 
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The Occurrence of Antibiotic-
Resistant Coliform Bacteria in the 
Triplett Creek Watershed, 
Rolvan County, Kentucky 
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and GEOFFREY W. GEARNER 
Dept. of Biological & Environmental Sciences 
Morehead State University 
Formalize the Study 
+Select sites on the Triplett Creek watershed, 
+Assay for total collforms, fecal coliforms and 
fecal strep by membrane filtration technique. 
+Test selected isolates for antibiotic resistivity 
by Kirby-Bauer Method. 
+ID isolates to species using EMB & APl-20E 
+Preliminary genetic investigation to 
determine basis of MDR isolates. 
Membrane Filtration Technique 
Watershed Monitoring 
+l\Iicrobiology students sample water 
samples for presence of fecal coliforms. 
+Noticed the occurrence of fecal coliforms 
of apparent human origin in TrJplett 
Creek (Ro,van Co.) watershed. 
+Subsequent antibiotic resistivity analysis 
of selected isolates revealed multiple drug 
resistant strains. 
'if_· t 
~ 
Typical Result 
I 
·I 
Bac-T Analysis Summary 
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Antibiotic Resistivity Results 
Coliform S11nple Elin APl·lOE ldenllflutio11 Re1bt.1oco 
HALD-2 + - ErclurlcMa toll C.,CC,I 
HAL"' • - bclr•richla coll AM,CD.,CC,S,C'l,TI 
PLANT·l • - Erclrtrlchla nil/ .ll<,Cl,CC,I 
STEPll-6 • - Euhrlchi<1 coll J.M,FOX,CJ;,CC,I 
STEPH~ • - EuhuicMa coll -.rox.cz,cc,1,V1M 
TACK-J 7-115-773 Kfrbllfllo p1111a•ula1 ui,ca,cc,1 
TACK-6 - J.J 15.773 Enttro&acttrt:foaua A.'l,,FOX,CC,I 
TOLW - 3.JIS-773 En1tro6ae1rrrloatt• .u1,rox.a..cc.1 
TOLW J.Jl5·77J En1tr1Jbcurclaut11 .,_, FOI, CZ, CC, I 
TOLL-' - J.Jl5·77l E111trobcur cloatttJ A)l,IDll,CZ,CC,X,CM 
TRIP.I • - Eulurld1J. roll ~a.cc,111,n 
' '.\1""lll'lpil.ilitll;!";\l''li'.-u•l"J..u!D;'ICll-.;o.1.im, U.:tC ~, II k':§rvlhriillQ'~4~z.;o;..&d!a,;0~ft'?''lli®~'fU .. «f<lt•mi <:)-1~m~•1~ ~fp=ldllillti'll'~t:qk~ 
DNA Analysis Result 
Kirby-Bauer Plate Result 
Genetic Analysis 
+Is the R-factor encoded by a plasmid gene? 
+utilize Orblgen's DNA EZ Matrix plasmid 
mini-prep protocol to isolate bacteria 
plasmids. 
+Analyze DNA by agarose gel electrophoresis. 
Other Genetic Elements? 
+Integrons, Conjugative Transposons, Shufflons 
*small mobile geneth: elemenll containing gene 
c•11elle1 fl•oked by recnmbla•llnn sequence1, 
*Agent1 or borizont.i gene tr•n1fer. 
*M•ny or the gene c•nettea include •ntlblotlc 
resi1tu1ce genes. 
*"rbne elements can be detected by polymera1e ch•ln 
reaction (PCR) 
transposon containing ermF and te/Q in the 
TRIP-1 isolate. 
2 
Acknowledgements 
+Institute of Regional Analysis & Public Policy 
(!RAPP) - MSU 
+Water TestJng Laboratory- l'tlSU 
*'red P•n 
*Rita Wrlghl 
+Fall 2000 & Spring 2001 BIOL 317 students 
+Mary \Villiams - Dental Student, U.K. 
+Tina Howard - M.S. Student, MSU 
+Brandon Houk- M.D. Student, U.K. 
+Trivikram Daso - Ph.D. Student, U.K. 
3 
( .. ; 
·-' 
Paper# 
A-049 
Assessment of Antibiotic Resistance in Fecal Coliform Bacteria in the 
Triplett Creek Watershed, Rowan County, Kentucky 
Tina Howard-Ousley and Geoffrey W. Geamer 
Morehead State University, Morehead KY 403 51 606-783-2803 
ADStract lKeVISeUJ 
'llte Trip!ca Crcft'.Wll.~ in Ro\\"!11\ CWllt;t. Kcntucly. has a loog tw.1ury orlOcal 
co1>1i.mliiadon ~ co ran~ stJitiu ~y:st~'lll and stnligbl rirc i..:1"0<:" Je('l)Sitiun. \\'11.:r 
samplci were ((•!Jeci.ed ti'ool a \'Klic:ty t1fllilt:1 :i1nng \~ 11111in ~r.:n1 .ill.i.l uib11ti1ri~ o( 
Tripltll Crl'd. 11~ n1embr~n~ fillnl~un 01tthnd lk~ l«N co O$..\o::U (~I «Jii'c"n (FCJ 
and(~ 111\."P'IC'•Cca\ (FS) dco.<:Ld~5. fCeD111115 r~n~Jh>m Ii toJ,G40ilOO ml. 
FC.lFS nlllMrnn~ £rum Ow 11:.a, lndlcatin~f.:QJ ~ti1minatlon ofbotl1 •nim:ll ;mJ 
bumaa origin. !'Im: ..:ulrw.:s 1>tn: uhlmn.:d from nled.ed r~"tll.I colirurm isulald IU'ld 
orWytt.J b;. 1ho': J.:ilby·Battt:r rrn:thro focwuibio1le rni:sti\'il)". Ei~ill." siA isc•Wt:i ~:re 
tmt>.1.i::;UndMll)C: wmbirlltliun or t1)'lhromycin. kDtli!Ol.•WI, ciprollo....idn. tdraC)>:tine, 
~•npU::Ulin. .:ef:v..:.!"1 • .:ad>::nieiUin, <lil\y..")di10!, tiiperGcilliB, i:.:fon1~imC". oroibcin. 
trim(1hnpri111 and strl.'Jlwmydn. /~A'Yo of~ iilolo11:$ evolu'1!ed exhihitcd r.;$i$tzincetc 
11~0 ur more omibiutics.. ?sol.:.~ w<::n: t.:::sted for rile pn::>'CllQl of d!l!I! l intt:grons by 
pol)'merau dlain n:4C:tion uli1Wng primeis (in<A and inlB) i;(l~ing to lb.; CO<U(t'led 
n:giom uflh.: ..:Lls;s I int.:gr:»c i,."l:llr: (lnd·J}. OtH:: 11rll6 i.;ola1~ cv-.il~cd 1""11:d P"'-'iiiw for 
~ lflll·I g.:o=. n~ J,xi.:o. ioo.i"41e 1Ji:i1 f«:il eto:u.imirudim .:if~ wazmJ~ if 4 ~0:11ti1111fos 
prol>Ji:in, :old th;d mulziple dmR, resist111l( ktct.etl.i ore reloti•"t"ly c.xrnaoo. TI1tO c~~ 
or d:us I inl~gmas. often:i.uix:i~1od "!ch muricf and a01ibioiic ~stance, appear tfl be: nire.. 
Introduction 
Tilf: l\ipkn Crc..-Jc w;i1~ ill Ro"'"Wi Cou111y, Kentucky, ha~ 
a longhi$'t01)· or ~rrai;;ht pip.: "'"'!H;~Jep.nitii.m QM fllil~ SC'plic 
f..l'Jol.tn• J...'"lll:bir~.; In~> il In lld;lition, the ~~ Jroin> taU!c 
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JWIUrcland h1 llx' li.lnflml pan 11fl11C .:<ollOI)'. the in.:re~MOJ 
Crlll:l\.-efO:C of antihiut.ic ~!:.ill emin~1m1:11bil bac'leri:i. •s ii i~ in 
I Figure l.MapofRowanC01.1nty1 
Its tributaries are h!nhllnllted ln 
Ken!ud;y. The main stem ofTr!ple-tt Credlh hlghll9lned In rOO; 
llow:and 1hecol1«11on situ lndlcatedb nars. 
cllnlcal l:.nlak,, b 1111-,;1!-JCM:umentcd Jl]1G1Wmerwn. ll>e:re ~re :1 
uitmber of ,gC11ctl.: i:kmtmll th.-ir i.lllnf<:t n:~isiance l() 11mibiufu;11, 
lnduJing inkgm11:1. lnte~iu 8"' ~~ QJ(ll.ure 1)-S!cnu th.:n ha..e 
tlie c.Jf"'Cily ta lnb::,grale gl:nt C&S~t~ inr.:i !heir c>.presric11 
r.:;:iOOlS. ~tany #'"~ .:.:i~ni :viol.•~ 1.:id:di: ~ rmJu.:t-c 
llmumo.:liare teist31l>!e tll • •·.)JiC'ly uf autihintiC"L CIHu t 
ini~as or..'Clir more comnt()nly Jn 1lre enwiC$ art.:! ~ 
p~on11'1:1. The obj.:«h·c ofdiis study was w 11:1~css 
><mibioi.ic ~isc.in1 foe:.! coli(111'1.11 hai:teria i~oL-.le..! fl'llcn the 
'rripletl Ctceli: •~ldmhtd in Rowlln C:o1mt;.. K..:nludy. :mJ tu 
:-uney t!IO»I: isc•l:d.c-c for lite pl't:1•:nci: 1•C d"-"'<J initjp\)(l~timca. 
TI1i~ projec1 was suppclflc:d by Mocdtc.ul State Univi:r.1ily'~ 
lnsti!u~ r.1r R.i::R,iotAl ,\l13l)>iS aitJ l'ubli.! Poli~-y 
Methods 
l. lOO-ml.samplc" were c.)Jl~~ 111 tlirc>: different tim<:5 Wm 
ntious ~ite!I in the Trip/el\ C«<::k watcr..hcd lx:1.W¢!1 Fcbl'tlllry 
o.ud 't-fovf'!n!x-r lOO:! tFli;µn: 1). 
2. 111<1 membr:u1e filtrnti1m 1e.:h11lql!ll wt1' us.:<! 10 1kte1minc l'ec:al 
C(11ifonn and f-l l<lrcpu..:oc~i Jcnsitlo:s. 
J. Sc;IC<;h:d fe<eal wllforo1 t'IUble!: •vi:reanal)"Zed foi: 11n1iblotlc 
resl~t.i~it:y ~· tl1c Kitby-B1111tt mcthod. 
4, Fo:a.I «lliform l!IObit.:s "'~aJ:.;o 11n:ilylld' furlht" presence or 
l"lft.ii I inti:,grun.' by r-.•lymctll~ cb:..in 1'!actiun. u~i113 thci 
following 11d11tcr~: 
Forv,a[d pri111~r: .S'.ATCATC:GTC:GTAG<\GACGTCGO.J' 
(inlA -hyhrWiNl In pc'lsitim1 I 19-240 orlhc fml·I ~'t'llC) 
ac..·crsc primu: s·- crrCAAGCITl'CTOOAC:CAGTTCiC-s· 
(intO- hybridilt'S 10 posilim1 1090-1111 oflhc: Ind-I f;Cnc:) 
·rncs.: primi:rsprodii.ie n SQ2-bp PCR. proJ1..:L 
.S. PCR pmduct~ "°f"' :u1:Uy.tt'd by l.2S%n;pit<>Sol ~el 
clc:cirophoresia. T•hli: l.J'«:d culiform aod f:.:.11 """Pl"u>e<;i COOMS per 100101.: 
~nJ FC:FS l'>l!i•>$. 
Results 
Tbe 5iteson 1hc Tripkit Cre¢1r: w~rmhc:d werca.11,s~cd at Shred JifT~O::nt 
1in1es. Bact•:tfologielll llll~Lrais shov.·cd tl111t1l1t f.:ail coliform. cuu111 r:tngcd 
from IJ !» J.IJ~O pa 100 ml.: whiti:llLt" t•c:FS r>1d1>,:..p>lcidfaJ ~lll<UW<1-f 
~,.11,1ruufft:Q1J i.:onllln1in:uio11, rultftl fium 0 Ill lll.lll (T:.hl~ h. 
llipil!-· sh.f<Xal colifom isola1cs wac 1~1ed D}.':lbm some: ;;(lll'lbiMlion of 
crphmlll}·tin, b.n:unycln. ciprofloncin, 1Clf$C)'Cline, ;impi<:illin. Ct'i:iwlin. 
cnrb.:nkillii~ dux~yclirn:. pipcra;:i!lin, ,,;c(uruximc,wnikadn, Uimctht1p:ri1n. a.nJ 
s1rer!om.~cin b.~ the Kirby-8.!ucnru::!hod. JJ uf1hi:86 08.~"•J l,;obt~ eo.·~lu:.teJ 
al1ibit..::d reo:Mran.:c to ,.,.., <1rnio~ :111libi1,1tii;s; "'irb lrinc oft!~ S6 (IOA%) sl..:i<lill!; 
rni11:11..:e t.> fo-c <'f gl<'1'c:ltlllibilltics.. Freq'ICILI!) l'frffist.l!O:C t.> individoo.I 
111nibioties o~ h1 ranlonJcr, MM: crytbromyi:itt (78.9%). a111pkillin ()i 2'~). 
t:elbrulin {19.8't). carbmiclllin ( 18.6%). ~~nyci11 (16.7".}. piprou:ilHn (1~11%), 
du~ycyclinc: (9.3%}. tetraer.;Hnc (7.~). lannmycln (4. 7!'1. dprollt!ueln {4.7%). 
amlk:v;in {l.3%}. bimi:llicprim (l.1%1. &nd c.:fomidmc ( 1.6%). 
AU U isnla~ wcr.: tYMlu:tt~d f,.rtho: (l~k'llU of d:i."' J inl~olJllll'I> hy pc>lyn1e~ 
duiio ~inn. Ocily t1nce>fihe R6 !41cd fl<»itivc forthe~ncc of~ brf.f./ g.:ne, 
isol~~ CCJ;S.01 (~figure 2). This iw?s.tc showed no n::sistan::e 10 lb: y.inc:l 
ohn.tibit1tioe<:St.:d. 
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